Company profile: Cellular Highways
1.1 - Company Overview
Company description
- Provider of microfluidic cell sorting solutions for research and clinical applications, including Highway1, a fluorescence-based sterile GMP benchtop sorter with Windows host PC and single-use cartridges; mAIvis automated imaging software; VACS thermal vapour bubble vortex deflection; GMP cell sorting systems, sterile GMP cartridges, and pilot-scale manufacturing and scaling services.
Products and services
- Highway1: Engineers a fluorescence-based benchtop cell sorter for sterile, GMP use, integrating a Windows host PC and sterile single-use cartridges for flexible swapping of input and output vessels (GMP-ready)
- VACS Technology: Produces cell deflection in a flow cytometer using a thermal vapour bubble to create a transient vortex for fast, gentle sorting akin to thermal inkjet actuation (vortex-actuated)
- MAIvis: Architects automated imaging software that adjusts sort parameters from camera images to improve purity and recovery during cell sorting, continuously refining instrument settings to optimize outcomes (automated)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cellular Highways
ProAxsis
HQ: United Kingdom
Website
- Description: Provider of laboratory-based immunoassays and rapid point-of-care tests for the capture, detection, and measurement of active protease biomarkers of disease, incorporating patented ProteaseTags smart molecules that selectively trap active proteases and deliver a visual readout in complex biological samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProAxsis company profile →
PreOmics
HQ: Germany
Website
- Description: Provider of innovative pre-analytics and sample preparation technologies for MS-based proteomics, supporting researchers in protein analysis. Offerings include iST kits for protein/peptide prep, TMT/iTRAQ-compatible chemical labeling (iST-NHS), minimized modifications in biofluids (iST-BCT), high-throughput positive-pressure prep (iST-PSI), peptide clean-up (iST Phoenix), and GFP IP enrichment (iST-Trap).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PreOmics company profile →
Bruker
HQ: United States
Website
- Description: Provider of analytical and medical instruments covering NMR, ESR, FT-IR and X-ray spectroscopy. MALDI Imaging to visualize molecular distribution in tissue sections; neofleX MALDI-TOF/TOF benchtop MS for protein and peptide analysis; Q6 NEWTON optical emission spectrometer for precise metal and alloy composition; BEAM FT-NIR for real-time process control of solid and semi-solid materials; and Dektak Pro profilometer for semiconductor surfaces.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bruker company profile →
BAC
HQ: United States
Website
- Description: Provider of affinity purification products and services for the biopharmaceutical market, with CaptureSelect products used from drug discovery to manufacturing of biopharmaceuticals, based on a proprietary platform integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BAC company profile →
ModiQuest Research
HQ: The Netherlands
Website
- Description: Provider of custom antibody generation and development services, specializing in monoclonal antibodies against difficult target antigens for R&D, diagnostic and therapeutic applications, using proprietary ModiFuse (hybridoma electrofusion), ModiSelect (B-cell selection) and ModiPhage (phage display) technologies to generate very large panels of monoclonal antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ModiQuest Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cellular Highways
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cellular Highways
2.2 - Growth funds investing in similar companies to Cellular Highways
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cellular Highways
4.2 - Public trading comparable groups for Cellular Highways
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →